Rare diseases
Investigational molecules
Locations
Comparing lenalidomide and methotrexate for patients with difficult-to-treat cutaneous lupus erythematosus
FranceA study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation
FranceStudy of xaluritamig plus abiraterone for men with metastatic castration-resistant prostate cancer who have not received chemotherapy
FranceStudy of fianlimab plus cemiplimab with chemotherapy or cemiplimab with chemotherapy for patients with pleural mesothelioma who have not received prior treatment
FranceA study comparing trifluridine, tipiracil, and fruquintinib versus trifluridine and tipiracil alone for patients with metastatic stomach or esophageal cancer
FranceA Study of ACP-204 Tartrate for Adults With Lewy Body Dementia Psychosis
FranceTesting sacituzumab govitecan and trastuzumab deruxtecan in alternating pattern for patients with HER2-low triple-negative breast cancer
FranceA Study Testing ACP-204 Tartrate Compared to Placebo for Adults with Lewy Body Dementia Psychosis
FranceStudy of Lisocabtagene Maraleucel as First Treatment for Adults with Primary Central Nervous System Lymphoma Who Cannot Have a Stem Cell Transplant
FranceA Study of fesoterodine and 5-[(1R,5R)-3-Azabicyclo[3.
FranceStudy of romiplostim given before heart surgery in patients with low platelet counts to improve blood clotting after surgery
FranceA study comparing BNT323 with chemotherapy in patients with HER2-expressing recurrent endometrial cancer who received previous treatment
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
